Company intelligence / Profile preview

China Neptunus Drugstore Holding

Shenzhen, Guangdong, China

Ownership: Private
Employees: ~30000
Development stage: Other

Overview

Neptunus Group operates as a diversified pharmaceutical company with commercial-stage products across pharmaceutical manufacturing, pharmaceutical logistics, and retail pharmacy operations. The company generates significant revenue from both pharmaceutical distribution (approximately 28 billion yuan in 2017) and retail pharmacy chains.

Modalities: Small moleculeRecombinant proteinVaccine
Industry: Biotech

Beyond the preview

Go deeper on China Neptunus Drugstore Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Neptunus Drugstore Holding.

Explore the full profile